Robert Bradway

Sales & Marketing

At BIO2024 experts agreed that in a period where pharma is deeply unpopular, the industry must be proactive in telling its story.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.